HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor-specific delivery and therapy by double-targeted DTX-CMCS-PEG-NGR conjugates.

AbstractPURPOSE:
To synthesize and evaluate the antitumor efficacy of double-targeted docetaxel (DTX)-carboxymethyl chitosan (CMCS)-PEG-NGR (DTX-CPN) conjugates that could target to CD13 over-expressed tumor neovascular endothelium cells and tumor cells.
METHODS:
DTX was conjugated to CMCS via biodegradable linker and cNGR was applied to endow the conjugates with double targeting ability. The physiochemical properties and stability of this DTX-CPN conjugates were characterized. Cellular uptake study was carried out to evaluate the targeting ability of DTX-CPN conjugates. Cytotoxicity and apoptosis analysis were conducted to evaluate in vitro antitumor effects. In vivo antitumor efficacy was investigated in B16 murine melanoma model.
RESULTS:
DTX-CPN conjugates could self-assemble into nanoparticles in water and were stable in plasma. cNGR modification could promote the cellular uptake of DTX-CPN conjugates in CD13 positive HUVEC and B16 cells, leading to more significant cytotoxicity and apoptosis effect than non-targeted conjugates. DTX-CPN conjugates also exhibited better antitumor effect than non-targeted conjugates and Duopafei® in a B16 murine melanoma model.
CONCLUSIONS:
Double-targeted DTX-CPN conjugates could efficiently target to tumor neovascular cells and tumor cells, and achieve good antitumor effects. DTX-CPN conjugates may be promising candidate for one-double targeting cancer therapy.
AuthorsFengxi Liu, Min Li, Chunxi Liu, Yongjun Liu, Yanchao Liang, Fengshan Wang, Na Zhang
JournalPharmaceutical research (Pharm Res) Vol. 31 Issue 2 Pg. 475-88 (Feb 2014) ISSN: 1573-904X [Electronic] United States
PMID24043295 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Drug Carriers
  • Taxoids
  • carboxymethyl-chitosan
  • Docetaxel
  • Chitosan
  • CD13 Antigens
Topics
  • Animals
  • Antineoplastic Agents (chemistry, pharmacology)
  • Apoptosis (drug effects)
  • CD13 Antigens (metabolism)
  • Cell Line
  • Cell Line, Tumor
  • Chitosan (analogs & derivatives, chemistry, pharmacology)
  • Docetaxel
  • Drug Carriers (chemistry)
  • Drug Delivery Systems (methods)
  • Drug Stability
  • Endothelial Cells (metabolism)
  • Hep G2 Cells
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Melanoma, Experimental
  • Mice
  • Nanoparticles (chemistry)
  • Taxoids (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: